Login

Longboard Pharmaceuticals, Inc. 4 SEC Filings

Filed On Filing
02 Dec 2024 Form 4: Lynch Casey, Director

Disposed of 74,162 Employee Stock Option (right to buy) (Disposition to Issuer)

02 Dec 2024 Form 4: Le Goff Corinne, Director

Disposed of 73,131 Employee Stock Option (right to buy) (Disposition to Issuer)

02 Dec 2024 Form 4: Schneider Phillip M, Director

Disposed of 72,828 Employee Stock Option (right to buy) (Disposition to Issuer)

02 Dec 2024 Form 4: Aurentz Vincent, Director

Disposed of 66,948 Employee Stock Option (right to buy) (Disposition to Issuer)

02 Dec 2024 Form 4: Kaye Randall, Executive Vice President & CMO

Disposed of 30,554 shares (Tender Offer) ($1.83M) · Disposed of 379,806 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 27,420 Restricted Stock Unit (Disposition to Issuer)

02 Dec 2024 Form 4: Roberts Brandi, Executive VP and CFO

Disposed of 439,660 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 22,990 Restricted Stock Unit (Disposition to Issuer)

02 Dec 2024 Form 4: Lind Kevin Robert, Director

Disposed of 363,740 shares (Tender Offer) ($21.8M) · Disposed of 1,106,144 Employee Stock Option (right to buy) (Disposition to Issuer) · Disposed of 22,000 Restricted Stock Unit (Disposition to Issuer)

02 Dec 2024 Form 4: Sekhri Paul J, Director

Disposed of 72,828 Employee Stock Option (right to buy) (Disposition to Issuer)

19 Nov 2024 Form 4: Kaye Randall, CMO

Received 30,554 shares by exercise or conversion ($183K)

13 Nov 2024 Form 4: Lind Kevin Robert, Director

Received 12,808 shares by exercise or conversion ($40K) · Gave 80,000 shares as a gift

29 Oct 2024 Form 4: Roberts Brandi, CFO

Granted 7,900 Retention Restricted Stock Units

29 Oct 2024 Form 4: Kaye Randall, CMO

Granted 9,500 Retention Restricted Stock Units

29 Oct 2024 Form 4: Lind Kevin Robert, Director

Granted 22,000 Retention Restricted Stock Units

16 Oct 2024 Form 4: Kaye Randall, CMO

Received 16,667 shares by exercise or conversion ($72.5K) · Sold 16,667 shares ($984K)

16 Sep 2024 Form 4: Kaye Randall, CMO

Received 16,666 shares by exercise or conversion ($72.5K) · Sold 16,666 shares ($527K)

13 Aug 2024 Form 4: Lind Kevin Robert, Director

Received 82,482 shares by exercise or conversion ($260K)

13 Aug 2024 Form 4: Kaye Randall, CMO

Bought 100 shares ($2.48K) · Sold 100 shares ($2.09K) · Received 16,667 shares by exercise or conversion ($72.5K) · 1 more

24 May 2024 Form 4: Sekhri Paul J, Director

Granted 22,500 Stock Option (Right to Buy)

24 May 2024 Form 4: Schneider Phillip M, Director

Granted 22,500 Stock Option (Right to Buy)

24 May 2024 Form 4: Lynch Casey, Director

Granted 22,500 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support